Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies

BACKGROUND: While response rates to anti-PD1 therapy are low in unselected metastatic castration resistant prostate cancer (mCRPC) patients, those with inactivating mutations in mismatch repair (MMR) genes (i.e. MMR deficiency; MMRd) or microsatellite instability (MSI) are thought likely to respond...

全面介紹

Na minha lista:
書目詳細資料
發表在:PLoS One
Main Authors: Graham, Laura S., Montgomery, Bruce, Cheng, Heather H., Yu, Evan Y., Nelson, Peter S., Pritchard, Colin, Erickson, Stephanie, Alva, Ajjai, Schweizer, Michael T.
格式: Artigo
語言:Inglês
出版: Public Library of Science 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7250457/
https://ncbi.nlm.nih.gov/pubmed/32453797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233260
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍